Technologies for RNA/DNA analysis
Gene Expression by quantitative RT-PCR

 

Skuldtech is specialized in the discovery of genomic and transcriptomic biomarkers. To reach its objectives, the company uses quantitative RT-PCR technology for monitoring patterns of expressed genes. 

 

Regarding the range of molecular biology and genomic technologies available in the field of Life Sciences, including Modern Medicine, Veterinary Science, Food-stuff, Agriculture, etc., the need for performing quantitative analyses of genes or DNA sequences has dramatically increased.
Skuldtech has gained tremendous experience in quantitative RT-PCR analysis.
In a high throughput routine, Skuldtech uses real-time PCR for monitoring global patterns of gene expression.
Real-time PCR provides an absolute quantitative analysis of gene expression and a rapid and precise confirmation of genetic changes.
Skuldtech’s expertise is focused on quantitative Real-Time PCR because this technique:

  Opens internal link in current windowIs the most sensitive technique for mRNA detection and quantification currently available.
  Opens internal link in current windowCan be used to quantify mRNA levels from much smaller samples.
  Opens internal link in current windowGives more accurate measurements and is much better adapted to analyses performed on large numbers of samples.
  Opens internal link in current windowHas been successfully developed and has become a reliable and easy to use standard method for the detection
      and/or quantification of   nucleic acid sequences.
  Opens internal link in current windowReduces hands-on time and increases reliability.
  Opens internal link in current windowHas been adopted for a wide range of new applications.

 

SKULDTECH AT A GLANCE

Skuldtech is specialized in the discovery of new Biomarkers and the development of Diagnostics focused on personalized medicine applications.
This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as innovative diagnostics
associated with new treatments, especially in
cancer, neurodegenerative and infectious diseases.